Market Projections Archives

07Nov

Where’s Walmart? Opening of Canadian CBD Market Prompts Speculation About Retail Giant

Comments are off for this post

By William Sumner, Hemp Business Journal Contributor Last month, rumors emerged that Walmart’s Canada division was conducting preliminary investigations into stocking its stores with CBD products, a move many consider to be inspired by Canada’s legalizing adult-use cannabis sales. Though details are not forthcoming, the very rumor of Walmart’s making moves into the CBD market […]

31Oct

Investors Waking Up to Hemp as Cannabis Stocks Retrace

Marijuana Insights

Comments are off for this post

By Sean Murphy, Director of Hemp Analytics, New Frontier Data Investors are waking up to the hemp industry. Hemp is proving its opportunity for financial returns, and potential for social and environmental impact. While the first five years of the cannabis stock “green rush” was dominated by retail over-the-counter (OTC) traders, family offices and high […]

24Oct

Differing State Hemp Regulations, Fees, Present Knotty Choices for Cultivators

Marijuana Insights

Comments are off for this post

By J.J. McCoy, Senior Managing Editor, New Frontier Data Not that the expanding patchwork of licensing regulations for hemp programs throughout the United States can be confusing and uneven, but had Johnny Appleseed faced all the challenges now confronting prospective American cultivators, he might have just stayed home. Make no mistake: Industrial hemp represents booming business, […]

20Oct

Canada Goes Fully Legal

Marijuana Insights

Comments are off for this post

By Yona Torres Editor New Frontier Data All eyes are on Canada as the country takes its first few steps into a fully legal cannabis landscape. As such, Canada is taking a measured pace in its rollout of legal adult-use cannabis. The country is currently limiting its product offerings and will not permit edibles. “We […]

17Oct

Mile High Labs Funding Round Underscores Contrasts in Cannabis Wholesaling

Marijuana Insights

Comments are off for this post

By J.J. McCoy, Senior Managing Editor, New Frontier Data Mile High Labs caught attention last week with the company’s announcement of a $35 million raise in what was described as the “largest Series A financing in the cannabis market history.” It was a newsworthy claim for the Colorado cannabis extraction company, and demonstrated its commitment toward […]

13Oct

New York State Holds ‘Listening Sessions’ on Cannabis Legalization

Marijuana Insights

Comments are off for this post

By Noah Potter, Of Counsel to Hoban Law Group Last month, New York State Governor Andrew Cuomo’s office announced a series of 15 listening sessions about cannabis legalization (including one in Manhattan last week) to hear public comment through October. Cuomo’s new approach contrasts with the process that resulted in enactment of the Compassionate Care […]

13Oct

Examining the Oceania Cannabis Market

Marijuana Insights

Comments are off for this post

By Yona Torres Editor New Frontier Data New Frontier Data’s most recent report release is an analysis of the budding cannabis market in Oceania (Australia, New Zealand, and the islands that comprise Melanesia, Micronesia, and Polynesia.) As the legal cannabis industry expands globally, Oceania serves as another example of significant and economically developed countries, including Australia, [...]

10Oct

Passage of Legalization Puts California Out Front for Hemp

Hemp, Legislation, Marijuana Insights

Comments are off for this post

By William Sumner, Hemp Business Journal Contributor A victory for the legal hemp industry was struck late last month as California Governor Jerry Brown signed into law SB 1409, to legalize hemp farming in the state. Included in the law are a series of provisions to clarify and resolve various conflicts between state laws and […]

07Oct

DEA’s Rescheduling of CBD Is No Industry Cure-All

Marijuana Insights

Comments are off for this post

By J.J. McCoy, Senior Managing Editor, for New Frontier Data Recent news that the U.S. Drug Enforcement Agency (DEA) is rescheduling cannabidiol (CBD) for use in FDA-approved medicine was warmly welcomed by the cannabis industry, but it felt confusingly tepid on delivery. Overall, the announcement is a boon for Big Pharma companies looking to develop and […]

03Oct

Hemp Stocks: A Look at Leading Public Hemp Companies

Marijuana Insights

Comments are off for this post

By William Sumner, Hemp Business Journal Contributor Last week, the hemp industry was abuzz with the news that the United States Drug Enforcement Administration (DEA) would move Epidiolex, a CBD-based drug derived from cannabis, from a Schedule I substance to a Schedule V substance. The scheduling does not explicitly pertain to CBD, but it does […]